Nano Drug Delivery Systems for Colon Cancer
Innovations, Challenges, and Applications
- 1st Edition - June 1, 2026
- Latest edition
- Editors: Arun Kumar Singh, Vipan Kumar, Pranav Kumar Prabhakar, Meenakshi Dhanawat, Neeraj Mishra
- Language: English
Nano Drug Delivery Systems for Colon Cancer: Innovations, Challenges, and Applications is a breakthrough exploration that delves into the latest advancements in colon cancer diagno… Read more
It serves as a vital resource, fostering interdisciplinary knowledge and advancements that have the potential to revolutionize colon cancer therapeutics. The book's interdisciplinary approach ensures it is a beacon of knowledge for those seeking to navigate and innovate within this critical field.
- Delivers an in-depth exploration of the design, synthesis, and application of nanodrug delivery systems
- Unveils groundbreaking and state-of-the-art approaches in colon cancer diagnosis and treatment, placing readers at the cutting edge of medical innovation
- Showcases how strategic design methodologies can dramatically boost therapeutic efficacy, paving the way for more effective colon cancer treatments
2. Current trends of targeted nanoparticulate carriers for the treatment of colon cancer
3. Lipid nanocarrier-based drug delivery for the treatment of colon cancer
4. Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy
5. siRNA polymer conjugates for the delivery of RNAi therapeutics for the treatment of Colon Cancer
6. Carbon-Based Quantum Dots and Nanotubes for Colon Cancer Targeting and Drug Delivery
7. Recent trends of extracellular vesicles for therapeutic intervention of Colon Cancer
8. Mitochondria-targeted drug delivery systems for the effective treatment of colon cancer
9. Revolutionizing Colon Cancer Care: Advances in Carbon-Based Materials as theranostic agents
10. Surface modified Metal Nanoparticles in Colon Cancer Therapy
11. Nano-based Phyto drug delivery systems for the management of colon cancer
12. Role of polymeric nanoparticles for the treatment of Colon cancer
13. Nanomicelles based drug delivery systems as for targeted therapy of colon cancer
14. Regulatory framework in the Nanomedicine targeting Colon Cancer
15. Current and future perspectives of nanomedicine in colon cancer treatment
- Edition: 1
- Latest edition
- Published: June 1, 2026
- Language: English
AS
Arun Kumar Singh
Arun Kumar Singh has completed M. Pharm (Pharmaceutics) from Galgotias University, Greater Noida, India. Mr. Singh joined as an assistant professor in the Department of Pharmacy, Vivekanand Global University Jaipur Rajasthan 303012. His area of interest is in the area of nano-formulation, blockchain, IoT, machine learning, cancer, artificial intelligence, big data, and neuroscience. He has authored one book with IOP publishing and has published 5 chapters in big data with River Publisher in Denmark. He has also published 20 review papers among which two are in Biochimica et Biophysica Acta (BBA) – Reviews on Cancer. He has published 26 books with various publishers like IOP, Elsevier, CRC PRESS, and Wiley.
VK
Vipan Kumar
Vipan Kumar is working as a Professor (Associate) at Department of Pharmaceutical Chemistry, JCDM College of Pharmacy, Sirsa. Dr. Kumar has more than 10 years of teaching and research experience. He has published dozens of publications in peer-reviewed international and national journal. He has authored 2 books. Dr. Kumar is an editorial and reviewer board member of several scientific journals of intentional repute. He is also serving as a CPCSEA Nominee in various institutes’ IAEC committees and served in University PGBOS committees.
PP
Pranav Kumar Prabhakar
MD
Meenakshi Dhanawat
NM
Neeraj Mishra
Dr. Mishra is working as Professor in Amity Institute of Pharmacy, Gwalior since July 2019. He has around twenty-two years of teaching and research experience. He has more than 140 publications of International and National repute in recent concepts of novel drug delivery systems, localized drug delivery, targeted and controlled drug delivery of nanocarriers/ microparticles for the treatment of breast, colon cancer, and neurodegenerative disorders. Dr. Mishra more than 4100 citations with h- index 36. The total cumulative Impact Factor of his published papers is more than 300 (as per SCOPUS). He has also written more than 25 Books and 45 book chapters in Elsevier, Bentham, Springer and Wiley Publication etc. He has also been granted 3 international patents and 6 Indian patents. Dr. Mishra is recipient of “Distinguished Professor Award” 2019 from DST-NSTMIS, SPAICS, Indore, and M.P. in September 2019. Dr. Mishra has received the “Distinguished Professor Award '' 2021 from Indian Pharmaceutical Association, MP State Branch, Indore. Dr Mishra has received Best Academician Award in the Indian Pharmacy Graduate Association, M.P. State International Conference held on 06th May 2023 at DAVV Auditorium, Indore, India. He is also received one MPCST Project entitled “Dual functional colon- targeted tofacitinib and probiotics loaded microparticles for the treatment of Inflammatory Bowel Disease (2023-24).